Fowler, Alan J.
Hebron, Michaeline
Missner, Alexander A.
Wang, Ruchong
Gao, Xiaokong
Kurd-Misto, Bahjat T.
Liu, Xiaoguang
Moussa, Charbel E.-H.
Funding for this research was provided by:
Georgetown University
Article History
First Online: 27 March 2019
Compliance with Ethical Standards
:
: These studies were supported by funding from Georgetown University to Charbel Moussa.
: Charbel Moussa is listed as an inventor of an issued US and international patent to use tyrosine kinase inhibitors to treat neurodegenerative diseases. No other author has any conflict of interest.
: All mouse studies were conducted in full compliance with the recommendations of the Georgetown University Animal Care and Use Committee under protocol 2016-1194.
: All data generated or analyzed during this study are included in this article (and the Electronic Supplementary Material).